TETRA Technologies, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TTI research report →
Range $9 – $12
Price Chart
About the company
TETRA Technologies, Inc. (TTI) is a diversified enterprise that delivers a range of services to the oil and gas industry. The company organizes its operations into two primary divisions: Completion Fluids & Products, and Water & Flowback Services.
- CEO
- Brady Murphy
- IPO
- 1990
- Employees
- 1,400
- HQ
- Spring, TX, US
Get TickerSpark's AI analysis on TTI
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $859.41M
- P/E
- 84.28
- Fwd P/E
- 23.54
- PEG
- -0.91
- P/S
- 1.37
- P/B
- 2.16
- EV/EBITDA
- 13.23
- Div Yield
- 0.00%
- Gross Margin
- 23.00%
- Op Margin
- 7.42%
- Net Margin
- 1.36%
- ROE
- 2.56%
- ROIC
- 2.69%
Latest fiscal year · YoY change
- Revenue
- $630.93M+5.3%
- Gross Profit
- $160.11M+14.4%
- Op Income
- $59.55M
- Net Income
- $3.00M-97.2%
- EPS
- $0.02-97.2%
- OCF Growth
- +174.8%
- FCF Growth
- +180.9%
- 52W High
- $12.54
- 52W Low
- $4.87
- 50D MA
- $5.94
- 200D MA
- $8.35
- Beta
- 1.26
- RSI (14)
- 46
- Avg Volume
- 2.28M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
TETRA posted a strong third quarter with record seasonal revenue, 10% year-over-year growth, and management signaling continued double-digit growth into Q4 and 2027 as deepwater, international, and industrial chemical demand broaden.· November 3, 2026
- Q3 revenue was $168 million, up 10% year over year and the highest third quarter in 10 years; adjusted EBITDA was $25.1 million, the second-highest Q3 in a decade.
- International revenue reached $68.8 million, or 41% of consolidated revenue, with strong contributions from Argentina and other overseas markets.
- Industrial chemicals revenue grew 32% year over year and semiconductor sales rose 48% year over year; water and flowback revenue grew 21% year over year with margins up 480 basis points to 16.7%.
- Management said Q4 2026 revenue and adjusted EBITDA should both be up double digits year over year, and it expects revenue and EBITDA to increase again in 2027.
- Arkansas Bromine Project remains on schedule and on budget, with first production targeted for early Q1 2028; the company also amended its term loan to add flexibility and lower borrowing costs.
Revenue was $168 million, up about 10% year over year, and the company said it was the highest third quarter revenue in the past 10 years. Income from continuing operations was $6.8 million, or $0.05 per share, versus $4.2 million, or $0.03 per share a year ago; adjusted net income per share was $0.06 versus $0.04. Adjusted EBITDA was $25.1 million, flat year over year and the second-highest Q3 in the past 10 years. Completion fluids and products revenue was $91.9 million, up 2% year over year; industrial chemicals revenue was up 32% year over year; and water and flowback services revenue was $76.1 million, up 21% year over year. Water and flowback adjusted EBITDA was $12.7 million, up 69% year over year, with margin at 16.7%; CFP adjusted EBITDA was $20.3 million, or 22.1% margin. For the first nine months, cash from operations was $31.3 million and capex was $77.6 million. The company ended with $84 million of cash and equivalents, $42 million of short-term investments, total debt of $184 million, net debt of $58 million, liquidity of $208 million, and net leverage of 0.7x. For guidance, management expects Q4 2026 consolidated revenue and adjusted EBITDA to be up double digits year over year. For 2027, it expects revenue and EBITDA to increase versus 2026, with completion fluids revenue and EBITDA also expected to rise, and CFP segment margins for full-year 2026 to land at the lower end of the 25%-30% range.
Brady Murphy framed the quarter as evidence that TETRA’s core business is strengthening across geographies and products, with international deepwater, industrial chemicals, and water/flowback all contributing. He emphasized that the company’s 2027 outlook is being driven by deepwater completions, international production testing, SandStorm adoption, electrolyte demand, and industrial chemicals, and said U.S. land improvement is not required for that outlook. His tone was confident and constructive, particularly around the company’s ONE TETRA 2030 targets and the progress on Arkansas, Oasis, and deeper exposure to technically demanding offshore markets.
Matt Sanderson focused on the financial mix behind the quarter: higher revenue, a $6.8 million income from continuing operations result, $0.06 adjusted EPS, and $25.1 million of adjusted EBITDA. He noted that CFP margins were pressured by lower Gulf of America deepwater activity and higher shipping costs on Middle East deliveries, and said full-year CFP margins should reach the low end of the 25%-30% range. On the balance sheet, he highlighted $84 million of cash, $42 million of short-term investments, $184 million of debt, $208 million of liquidity, and a 0.7x net leverage ratio, plus the amended $190 million term loan that lowers margins by 75 bps to SOFR +5%, extends maturity to December 31, 2030, and defers about $19 million of principal payments to 2030.
Analysts pressed management on permitting timing for the desal/Oasis projects, but Brady said the timing is not under TETRA’s control and that customers, as permittees, must secure approvals from TCEQ and EPA. Management said the pipeline now includes seven projects, with four tied to data centers and three focused on produced-water disposal, but it would not size revenue potential yet because project specs and permits are still evolving. Questions also focused on bromine costs, Z-Lite, deepwater growth, Argentina, semiconductor exposure, and electrolytes; management said third-party bromine purchases will continue through 2026 and 2027, Z-Lite is a midpoint product between standard fluids and full Neptune economics, Argentina should still deliver double-digit growth in 2027, and the semiconductor business remains a relatively small but sustainable growth opportunity.
The call reinforced that TETRA’s base business is growing in multiple places at once: international deepwater, SandStorm/production testing, industrial chemicals, and semiconductor-related demand. Management also pointed to a healthier 2027 setup, with more offshore activity, rising Z-Lite and Neptune opportunities, and a balance sheet that now has more room to fund Arkansas and other initiatives.
The biggest near-term risk discussed was permitting and timing for the Oasis/desal projects, which management does not control and cannot forecast precisely. In addition, CFP margins were pressured by lower deepwater activity and shipping cost inflation, and the company still depends on third-party bromine purchases until its Arkansas plant comes online in 2028.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 93.9%
- Shares Outstanding
- 148.43M
- Float Shares
- 139.41M
of shares held by institutions
251 13F filers
Buy/sell ratio 0.50. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 12.52M | ▲ 294.11K |
| Vanguard Group Inc | 8.32M | ▼ 138.86K |
| Neuberger Berman Group LLC | 7.37M | ▼ 1.30M |
| Vanguard Capital Management LLC | 6.11M | ▼ 12.54K |
| Ameriprise Financial Inc | 6.07M | ▲ 549.68K |
| Needham Investment Management LLC | 5.65M | ▲ 2.28M |
| Franklin Templeton Inc | 5.32M | ▲ 3.50M |
| Cramer Rosenthal Mcglynn LLC | 5.07M | ▲ 3.31M |
| American Century Companies Inc | 4.89M | ▲ 357.12K |
| Driehaus Capital Management LLC | 4.37M | ▲ 782.82K |
| State Street Corp | 4.36M | ▲ 402.77K |
| Vaughan Nelson Investment Management, L.P. | 3.67M | ▼ 207.13K |
Held by 250 ETFs
Biggest fund positions in TTI by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 4, 26 | Moeller Timothy C | other | 25,000 |
| Oct 4, 26 | Moeller Timothy C | other | 9,838 |
| Oct 4, 26 | Moeller Timothy C | other | 25,000 |
| Sep 29, 26 | Kokenes Kathrine | other | 9,881 |
| Sep 29, 26 | Kokenes Kathrine | other | 9,881 |
| Sep 29, 26 | Kokenes Kathrine | other | 3,691 |
| Sep 2, 26 | John Angela D | buy | 10,000 |
| Aug 25, 26 | Moeller Timothy C | other | 13,599 |
| Aug 25, 26 | Moeller Timothy C | other | 5,352 |
| Aug 25, 26 | Moeller Timothy C | other | 13,612 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our TTI coverage
Recent articles, reports, and earnings notes.
No research on TTI yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TTI report →Tvardi Therapeutics Advances Next-Generation Oral STAT3 Inhibitor TTI-109 Toward IND in Inflammatory Bowel Disease Following FDA Pre-IND Feedback
globenewswire.com · Nov 19
Thiogenesis to Present at the Cystinosis Research Network Scientific Symposium
newsfilecorp.com · Nov 12
What Tetra Technologies (TTI) Said on Its Q3 Earnings Call
defenseworld.net · Nov 6
What Tetra Technologies (TTI) Said on Its Q3 Earnings Call
marketbeat.com · Nov 4
TETRA Technologies, Inc. (TTI) Q3 2026 Earnings Call Transcript
seekingalpha.com · Nov 3
Tetra Technologies (TTI) Q3 Earnings and Revenues Beat Estimates
zacks.com · Nov 2
TETRA TECHNOLOGIES, INC. REPORTS STRONG THIRD-QUARTER 2026 RESULTS
prnewswire.com · Nov 2
Thiogenesis Announces FDA Clearance of IND for Nephropathic Cystinosis
newsfilecorp.com · Oct 22
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.